• #581508
  • 11
  • Sanofi Pasteur #589-05

Menactra® Meningitis Vaccine Indicated for People 9 Months Through 55 Years of Age Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL

MENACTRA疫苗,六世4 mcG/.05ML (5/CT)

Sanofi Pasteur 589-05
Menactra® Meningitis Vaccine Indicated for People 9 Months Through 55 Years of Age Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL
Compare
Features
  • Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
  • Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
  • In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart
  • More …
Log In to Order
or
View Alternatives

Product Specifications

Features
  • Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
  • Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
  • In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart
  • Do not administer this product intravenously or subcutaneously
  • Requires refrigeration
More Information

Professionals Also Viewed

  • #1064517
  • 592
  • Glaxo Smith Kline #58160095509
Menveo® Meningitis Vaccine Indicated for People 2 Months Through 55 Years of Age Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Preservative Free 10 mcg - 5 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL
  • MENVEO is a vaccine indicated for active immunization to prevent invas …
  • MENVEO is supplied in two vials that must be combined prior to adminis …
  • #1047522
  • 486
  • Glaxo Smith Kline #58160097620
Bexsero® Meningitis Vaccine Indicated for People 10 Through 25 Years of Age Meningococcal Group B Vaccine 50 mcg - 50 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL
  • BEXSERO is a vaccine indicated for active immunization to prevent inva …
  • BEXSERO is approved for use in individuals 10 through 25 years of age
  • BEXSERO is supplied as a 0.5 mL suspension in a glass pre-filled syrin …
  • #944569
  • 158
  • Pfizer #00005010005
Trumenba® Meningitis Vaccine Indicated for People 10 Through 25 Years of Age Meningococcal Group B Vaccine 120 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL
  • Trumenba is indicated for active immunization to prevent invasive dise …
  • Trumenba is a suspension for intramuscular injection in 0.5 mL single- …
  • 5 Syringes
  • #944570
  • 82
  • Pfizer #00005010010
Trumenba® Meningitis Vaccine Indicated for People 10 Through 25 Years of Age Meningococcal Group B Vaccine 120 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL
  • Trumenba is indicated for active immunization to prevent invasive dise …
  • Trumenba is a suspension for intramuscular injection in 0.5 mL single- …
  • 10 Syringes
Compare Products(0) Clear Compare